ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,947.50
1.68%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. AQSE
  6. Apollon Formularies plc (APOL)

  7. Apollon Formularies plc (APOL) News

Apollon Formularies (APOL)

Apollon Formularies plc
Date:
Sort by:
 Showing the most relevant articles for your search:AQSE:APOL
DateTimeSourceHeadlineSymbolCompany
03/05/202412:59UK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
01/05/202415:00UK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
20/02/202410:59UK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
02/01/202408:18UK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
05/12/202311:59UK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
21/11/202311:51UK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
29/09/202307:00UK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
19/09/202309:18UK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
03/08/202310:51UK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
02/08/202312:19UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
24/07/202311:00UK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
30/06/202317:32UK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
10/05/202317:05UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
11/04/202314:00UK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
21/03/202312:00UK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
15/03/202307:00UK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
12/01/202307:00UK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
30/12/202212:37UK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
02/12/202207:00UK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
30/09/202209:50UK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
13/09/202207:02UK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
02/08/202209:11UK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
26/07/202207:00UK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
30/06/202216:29UK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
30/06/202212:33UK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
17/06/202213:23UK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
05/05/202212:07UK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
02/03/202207:01UK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
09/02/202207:00UK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
03/02/202206:59UK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
 Showing the most relevant articles for your search:AQSE:APOL

Your Recent History

LSE
AGL
Angle
LSE
SCLP
Scancell
LSE
SCE
Surface Transforms
LSE
EEE
Empire Metals
LSE
FUM
Futura Medical
LSE
SRSP
Sirius Petroleum
LSE
MIN
Minoan
LSE
GFM
Griffin Mining
LSE
AAU
Ariana Resources
LSE
ENET
Ethernity Networks
LSE
TERN
Tern
LSE
JAY
Bluejay Mining
LSE
GKP
Gulf Keystone Petroleum
LSE
BARC
Barclays
LSE
YU.
Yu
LSE
TRIN
Trinity Exploration & Pr...
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved